A Clogged Gutter Mechanism for Protease Inhibitors

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2002 Jul 27

PMID 12142461

Citations 64

Authors

Evette S Radisky

Daniel E Koshland Jr

Affiliations

Soon will be listed here.

Abstract

A classical peptide inhibitor of serine proteases that is hydrolyzed approximately 10(7) times more slowly than a good substrate is shown to form an acyl-enzyme intermediate rapidly. Despite this quick first step, further reaction is slowed dramatically because of tight and oriented binding of the cleaved peptide, preventing acyl-enzyme hydrolysis and favoring the reverse reaction. Moreover, this mechanism appears to be common to a large class of tight-binding serine protease inhibitors that mimic good substrates. The arrest of enzymatic reaction at the intermediate stage allowed us to determine that the consensus nucleophilic attack angle is close to 90 degrees in the reactive Michaelis complexes.

Citing Articles

Recognition and cleavage of human tRNA methyltransferase TRMT1 by the SARS-CoV-2 main protease.

DOliviera A, Dai X, Mottaghinia S, Olson S, Geissler E, Etienne L Elife. 2025; 12.

PMID: 39773525 PMC: 11706605. DOI: 10.7554/eLife.91168.

Kunitz-type trypsin inhibitor from durian (Durio zibethinus) employs a distinct loop for trypsin inhibition.

Deetanya P, Limsardsanakij K, Sabat G, Pattaradilokrat S, Chaisuekul C, Wangkanont K Protein Sci. 2024; 33(12):e5230.

PMID: 39565068 PMC: 11577449. DOI: 10.1002/pro.5230.

Prebound State Discovered in the Unbinding Pathway of Fluorinated Variants of the Trypsin-BPTI Complex Using Random Acceleration Molecular Dynamics Simulations.

Wehrhan L, Keller B J Chem Inf Model. 2024; 64(13):5194-5206.

PMID: 38870039 PMC: 11234359. DOI: 10.1021/acs.jcim.4c00338.

Cystine-knot peptide inhibitors of HTRA1 bind to a cryptic pocket within the active site region.

Li Y, Wei Y, Ultsch M, Li W, Tang W, Tombling B Nat Commun. 2024; 15(1):4359.

PMID: 38777835 PMC: 11111691. DOI: 10.1038/s41467-024-48655-w.

Reprogramming biocatalytic futile cycles through computational engineering of stereochemical promiscuity to create an amine racemase.

Han S, Jang Y, Kook J, Jang J, Shin J Nat Commun. 2024; 15(1):49.

PMID: 38169460 PMC: 10761954. DOI: 10.1038/s41467-023-44218-7.

References

Komiyama T, Fuller R . Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin. Biochemistry. 2000; 39(49):15156-65. DOI: 10.1021/bi001907c. View

Wells J, Ferrari E, Henner D, Estell D, Chen E . Cloning, sequencing, and secretion of Bacillus amyloliquefaciens subtilisin in Bacillus subtilis. Nucleic Acids Res. 1983; 11(22):7911-25. PMC: 326549. DOI: 10.1093/nar/11.22.7911. View

Tyndall J, Fairlie D . Conformational homogeneity in molecular recognition by proteolytic enzymes. J Mol Recognit. 1999; 12(6):363-70. DOI: 10.1002/(SICI)1099-1352(199911/12)12:6<363::AID-JMR478>3.0.CO;2-M. View

Jackson S, Moracci M, Elmasry N, Johnson C, Fersht A . Effect of cavity-creating mutations in the hydrophobic core of chymotrypsin inhibitor 2. Biochemistry. 1993; 32(42):11259-69. DOI: 10.1021/bi00093a001. View

Bizzozero O . Chemical analysis of acylation sites and species. Methods Enzymol. 1995; 250:361-79. DOI: 10.1016/0076-6879(95)50085-5. View

Luckett S, Garcia R, Barker J, Konarev A, Shewry P, Clarke A . High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds. J Mol Biol. 1999; 290(2):525-33. DOI: 10.1006/jmbi.1999.2891. View

Fujinaga M, Read R, Sielecki A, Ardelt W, Laskowski Jr M, James M . Refined crystal structure of the molecular complex of Streptomyces griseus protease B, a serine protease, with the third domain of the ovomucoid inhibitor from turkey. Proc Natl Acad Sci U S A. 1982; 79(16):4868-72. PMC: 346786. DOI: 10.1073/pnas.79.16.4868. View

Read R, Fujinaga M, Sielecki A, James M . Structure of the complex of Streptomyces griseus protease B and the third domain of the turkey ovomucoid inhibitor at 1.8-A resolution. Biochemistry. 1983; 22(19):4420-33. DOI: 10.1021/bi00288a012. View

Laskowski Jr M, Kato I . Protein inhibitors of proteinases. Annu Rev Biochem. 1980; 49:593-626. DOI: 10.1146/annurev.bi.49.070180.003113. View

10.

Tamura A, Kanaori K, Kojima S, Kumagai I, Miura K, Akasaka K . Mechanisms of temporary inhibition in Streptomyces subtilisin inhibitor induced by an amino acid substitution, tryptophan 86 replaced by histidine. Biochemistry. 1991; 30(21):5275-86. DOI: 10.1021/bi00235a022. View

11.

Martin P, Malkowski M, Dimaio J, Konishi Y, Ni F, EDWARDS B . Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues. Biochemistry. 1996; 35(40):13030-9. DOI: 10.1021/bi960656y. View

12.

Laskowski Jr M, FINKENSTADT W . Study of protein-protein and of protein-ligand interactions by potentiometric methods. Methods Enzymol. 1972; 26:193-277. DOI: 10.1016/s0076-6879(72)26012-8. View

13.

Murshudov G, Vagin A, Dodson E . Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr. 1997; 53(Pt 3):240-55. DOI: 10.1107/S0907444996012255. View

14.

Vincent J, PUDLES J, Lazdunski M . The association of anhydrotrypsin with the pancreatic trypsin inhibitors. Biochemistry. 1974; 13(20):4205-11. DOI: 10.1021/bi00717a023. View

15.

McPhalen C, James M . Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo. Biochemistry. 1988; 27(17):6582-98. View

16.

Brunger A, Adams P, Clore G, DeLano W, Gros P, Grosse-Kunstleve R . Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. 1998; 54(Pt 5):905-21. DOI: 10.1107/s0907444998003254. View

17.

Jackson S, Fersht A . Contribution of residues in the reactive site loop of chymotrypsin inhibitor 2 to protein stability and activity. Biochemistry. 1994; 33(46):13880-7. DOI: 10.1021/bi00250a042. View

18.

Yang M, Ferrari E, Henner D . Cloning of the neutral protease gene of Bacillus subtilis and the use of the cloned gene to create an in vitro-derived deletion mutation. J Bacteriol. 1984; 160(1):15-21. PMC: 214674. DOI: 10.1128/jb.160.1.15-21.1984. View

19.

Cai M, Huang Y, Prakash O, Wen L, Dunkelbarger S, Huang J . Differential modulation of binding loop flexibility and stability by Arg50 and Arg52 in Cucurbita maxima trypsin inhibitor-V deduced by trypsin-catalyzed hydrolysis and NMR spectroscopy. Biochemistry. 1996; 35(15):4784-94. DOI: 10.1021/bi953038a. View

20.

Heinz D, Hyberts S, Peng J, Priestle J, Wagner G, Grutter M . Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: functional and structural investigation. Biochemistry. 1992; 31(37):8755-66. DOI: 10.1021/bi00152a011. View